Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.00% | -47.18% | -142.78% | 34.22% | -145.72% |
| Total Depreciation and Amortization | 50.61% | -11.61% | 11.24% | 10.21% | -21.68% |
| Total Amortization of Deferred Charges | 31.82% | -19.44% | -88.80% | -- | -- |
| Total Other Non-Cash Items | 122.67% | 139.80% | -5.60% | -87.20% | -25.58% |
| Change in Net Operating Assets | -55.25% | 374.90% | -1,048.17% | -3,302.40% | 208.34% |
| Cash from Operations | 9.76% | 51.39% | -568.06% | -98.64% | -648.58% |
| Capital Expenditure | 96.65% | 88.41% | 26.25% | 17.70% | -68.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.65% | 88.41% | 26.50% | 25.10% | -68.64% |
| Total Debt Issued | -- | -100.44% | -- | 162.56% | -100.00% |
| Total Debt Repaid | 30.96% | 26.14% | -7.05% | -102.36% | 19.29% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.92% | -100.00% | 199.91% | -67.79% | 113,066.67% |
| Cash from Financing | 159.78% | -101.71% | 82.74% | -25.39% | -89.29% |
| Foreign Exchange rate Adjustments | 623.26% | 206.43% | 75.32% | -98.54% | 98.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.50% | -115.93% | -292.18% | -1,459.15% | -343.27% |
